Bio-Connect

Fibulin 2 antibody

GTX105108
GeneTex
ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
TargetFBLN2
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    Fibulin 2 antibody
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1:500-1:3000. IHC-P: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    1.19 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID2199
  • Target name
    FBLN2
  • Target description
    fibulin 2
  • Target synonyms
    fibulin-2, FIBL-2
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDP98095
  • Protein Name
    Fibulin-2
  • Scientific Description
    This gene encodes an extracellular matrix protein, which belongs to the fibulin family. This protein binds various extracellular ligands and calcium. It may play a role during organ development, in particular, during the differentiation of heart, skeletal and neuronal structures. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq]
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Patel MR, Weaver AM. Astrocyte-derived small extracellular vesicles promote synapse formation via fibulin-2-mediated TGF-β signaling. Cell Rep. 2021,34(10):108829. doi: 10.1016/j.celrep.2021.108829
    Read this paper
  • Kanan Y, Brobst D, Han Z, et al. Fibulin 2, a tyrosine O-sulfated protein, is up-regulated following retinal detachment. J Biol Chem. 2014,289(19):13419-33. doi: 10.1074/jbc.M114.562157
    Read this paper
  • Slany A, Haudek-Prinz V, Meshcheryakova A, et al. Extracellular matrix remodeling by bone marrow fibroblast-like cells correlates with disease progression in multiple myeloma. J Proteome Res. 2014,13(2):844-54. doi: 10.1021/pr400881p
    Read this paper
  • Karakikes I, Chaanine AH, Kang S, et al. Therapeutic cardiac-targeted delivery of miR-1 reverses pressure overload-induced cardiac hypertrophy and attenuates pathological remodeling. J Am Heart Assoc. 2013,2(2):e000078. doi: 10.1161/JAHA.113.000078
    Read this paper